← FDA Drug Approvals (Drugs@FDA)

BAVENCIO

BLA · Biologics License Application · Sponsor: EMD SERONO INC · Approved 2017-05-09

Drug application

FDA Application #

BLA761078

Application type

Biologics License Application

Brand name

BAVENCIO

Generic name

Avelumab

Active ingredients

AVELUMAB

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EMD SERONO INC

First approval

2017-05-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown